This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998:234:57-61.

doi: 10.1007/978-3-642-72153-3_4.

Saporin immunotoxins

Affiliations

PMID: 9670612
DOI: 10.1007/978-3-642-72153-3_4

Review

Saporin immunotoxins

D J Flavell. Curr Top Microbiol Immunol. 1998.

. 1998:234:57-61.

doi: 10.1007/978-3-642-72153-3_4.

Author

Affiliation

¹ Simon Flayell Leukaemia Research Unit, University Department of Pathology, Southampton General Hospital, Hampshire, UK.

PMID: 9670612
DOI: 10.1007/978-3-642-72153-3_4

No abstract available

PubMed Disclaimer

Similar articles

Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation.
Tazzari PL, Bolognesi A, de Totero D, Falini B, Lemoli RM, Soria MR, Pileri S, Gobbi M, Stein H, Flenghi L, et al. Tazzari PL, et al. Br J Haematol. 1992 Jun;81(2):203-11. doi: 10.1111/j.1365-2141.1992.tb08208.x. Br J Haematol. 1992. PMID: 1322690
Intra-thecal treatment of leptomeningeal lymphoma with immunotoxin.
Urch CE, George AJ, Stevenson GT, Bolognesi A, Stirpe F, Weller R, Glennie MJ. Urch CE, et al. Int J Cancer. 1991 Apr 1;47(6):909-15. doi: 10.1002/ijc.2910470621. Int J Cancer. 1991. PMID: 2010234
Comparison of immunotoxins bearing a single saporin molecule with multiple toxin conjugates.
Flavell DJ, Flavell SU. Flavell DJ, et al. Methods Mol Biol. 2001;166:87-100. doi: 10.1385/1-59259-114-0:87. Methods Mol Biol. 2001. PMID: 11217378 Review. No abstract available.
Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice.
Flavell DJ, Noss A, Pulford KA, Ling N, Flavell SU. Flavell DJ, et al. Cancer Res. 1997 Nov 1;57(21):4824-9. Cancer Res. 1997. PMID: 9354445
Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
Ferrini S, Sforzini S, Canevari S. Ferrini S, et al. Methods Mol Biol. 2001;166:177-92. doi: 10.1385/1-59259-114-0:177. Methods Mol Biol. 2001. PMID: 11217367 Review. No abstract available.

See all similar articles

Cited by

Polymyxins Facilitate Entry into Mammalian Cells.
Hamill KM, McCoy LS, Wexselblatt E, Esko JD, Tor Y. Hamill KM, et al. Chem Sci. 2016 Aug 1;7(8):5059-5068. doi: 10.1039/C6SC00488A. Epub 2016 Apr 25. Chem Sci. 2016. PMID: 28044098 Free PMC article.
Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven disease.
Akiyoshi H, Chung JS, Tomihari M, Cruz PD Jr, Ariizumi K. Akiyoshi H, et al. J Immunol. 2010 Apr 1;184(7):3554-61. doi: 10.4049/jimmunol.0903250. Epub 2010 Feb 22. J Immunol. 2010. PMID: 20176742 Free PMC article.
Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
Polito L, Bortolotti M, Pedrazzi M, Bolognesi A. Polito L, et al. Toxins (Basel). 2011 Jun;3(6):697-720. doi: 10.3390/toxins3060697. Epub 2011 Jun 22. Toxins (Basel). 2011. PMID: 22069735 Free PMC article. Review.
Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience.
Flavell DJ, Flavell SU. Flavell DJ, et al. Toxins (Basel). 2022 Aug 18;14(8):563. doi: 10.3390/toxins14080563. Toxins (Basel). 2022. PMID: 36006226 Free PMC article. Review.
Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU. Flavell DJ, et al. Br J Cancer. 2001 Feb;84(4):571-8. doi: 10.1054/bjoc.2000.1633. Br J Cancer. 2001. PMID: 11207056 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database